Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Dawson

Showing results (491-500 of 533) with videos related to

Pageof 54
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|July 21, 2009
Inactivating germ-line and somatic mutations in polypeptide N-acetylgalactosaminyltransferase 12 in human colon cancersKishore Guda, Helen Moinova, Jian He, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 12, 2009
Epigenetic changes during disease progression in a murine model of human chronic lymphocytic leukemiaShih-Shih Chen, Aparna Raval, Amy J Johnson, et al.
Cell Reports|January 12, 2022
Reprogramming of nucleotide metabolism by interferon confers dependence on the replication stress response pathway in pancreatic cancer cellsEvan R Abt, Thuc M Le, Amanda M Dann, et al.
JCI Insight|June 10, 2025
Emerin is an effector of oncogenic KRAS-driven nuclear dynamics in pancreatic cancerLuis F Flores, David L Marks, Renzo E Vera, et al.
BMC Genomics|December 7, 2007
Restriction landmark genomic scanning (RLGS) spot identification by second generation virtual RLGS in multiple genomes with multiple enzyme combinationsDominic J Smiraglia, Ramakrishnan Kazhiyur-Mannar, Christopher C Oakes, et al.
Nature Communications|January 31, 2026
Neoadjuvant modified FOLFIRINOX plus nivolumab in borderline-resectable pancreatic ductal adenocarcinoma: a pilot phase 1 trialZev A Wainberg, Jason M Link, Alykhan Premji, et al.
Biorxiv : the Preprint Server for Biology|October 14, 2024
nSMase2-mediated exosome secretion shapes the tumor microenvironment to immunologically support pancreatic cancerAudrey M Hendley, Sudipta Ashe, Atsushi Urano, et al.
Cell|September 27, 2014
Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapyMara H Sherman, Ruth T Yu, Dannielle D Engle, et al.
The Journal of Clinical Investigation|September 9, 2025
Antithrombin-binding heparan sulfate is ubiquitously expressed in epithelial cells and suppresses pancreatic tumorigenesisThomas Mandel Clausen, Ryan J Weiss, Jacob R Tremblay, et al.
Nature Communications|July 8, 2021
Whole-genome profiling of nasopharyngeal carcinoma reveals viral-host co-operation in inflammatory NF-κB activation and immune escapeJeff P Bruce, Ka-Fai To, Vivian W Y Lui, et al.
Pageof 54

Showing results (491-500 of 533) with videos related to

Sort By:
Pageof 54
Proceedings of the National Academy of Sciences of the United States of America|July 21, 2009
Inactivating germ-line and somatic mutations in polypeptide N-acetylgalactosaminyltransferase 12 in human colon cancersKishore Guda, Helen Moinova, Jian He, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 12, 2009
Epigenetic changes during disease progression in a murine model of human chronic lymphocytic leukemiaShih-Shih Chen, Aparna Raval, Amy J Johnson, et al.
Cell Reports|January 12, 2022
Reprogramming of nucleotide metabolism by interferon confers dependence on the replication stress response pathway in pancreatic cancer cellsEvan R Abt, Thuc M Le, Amanda M Dann, et al.
JCI Insight|June 10, 2025
Emerin is an effector of oncogenic KRAS-driven nuclear dynamics in pancreatic cancerLuis F Flores, David L Marks, Renzo E Vera, et al.
BMC Genomics|December 7, 2007
Restriction landmark genomic scanning (RLGS) spot identification by second generation virtual RLGS in multiple genomes with multiple enzyme combinationsDominic J Smiraglia, Ramakrishnan Kazhiyur-Mannar, Christopher C Oakes, et al.
Nature Communications|January 31, 2026
Neoadjuvant modified FOLFIRINOX plus nivolumab in borderline-resectable pancreatic ductal adenocarcinoma: a pilot phase 1 trialZev A Wainberg, Jason M Link, Alykhan Premji, et al.
Biorxiv : the Preprint Server for Biology|October 14, 2024
nSMase2-mediated exosome secretion shapes the tumor microenvironment to immunologically support pancreatic cancerAudrey M Hendley, Sudipta Ashe, Atsushi Urano, et al.
Cell|September 27, 2014
Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapyMara H Sherman, Ruth T Yu, Dannielle D Engle, et al.
The Journal of Clinical Investigation|September 9, 2025
Antithrombin-binding heparan sulfate is ubiquitously expressed in epithelial cells and suppresses pancreatic tumorigenesisThomas Mandel Clausen, Ryan J Weiss, Jacob R Tremblay, et al.
Nature Communications|July 8, 2021
Whole-genome profiling of nasopharyngeal carcinoma reveals viral-host co-operation in inflammatory NF-κB activation and immune escapeJeff P Bruce, Ka-Fai To, Vivian W Y Lui, et al.
Pageof 54